Sharon Tetlow, Acting CFO & Treasurer at Ocera Therapeutics, Inc. (OCRX), bought 3,000 shares at $5.83 ($17K) on 2014-07-11, disclosed to the SEC on 2014-07-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.